Accessibility Menu
 
StageZero Life Sciences logo

StageZero Life Sciences

(OTC) SZLSF

Current Price$0.00
Market Cap$61,800
Since IPO (2011)-100%
5 Year-100%
1 Year-69%
1 Month-90%

StageZero Life Sciences Financials at a Glance

Market Cap

$61,800

Revenue (TTM)

$2.15M

Net Income (TTM)

$2.26M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$0.00

Volume

500

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.07

SZLSF News

No articles available.

SZLSF: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About StageZero Life Sciences

Industry

Biotechnology

Employees

40

CEO

James R. Howard-Tripp

Headquarters

Richmond Hill, ON L4B 3B2, CA

SZLSF Financials

Key Financial Metrics (TTM)

Gross Margin

-11%

Operating Margin

-2%

Net Income Margin

-3%

Return on Equity

0%

Return on Capital

1%

Return on Assets

-16%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$61.80K

Shares Outstanding

123.55M

Volume

500

Short Interest

0.00%

Avg. Volume

0

Financials (TTM)

Gross Profit

$403.75K

Operating Income

$7.75M

EBITDA

$10.27M

Operating Cash Flow

$3.53M

Capital Expenditure

$0.00

Free Cash Flow

$3.53M

Cash & ST Invst.

$15.68K

Total Debt

$1.80M

StageZero Life Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$499.66K

-37.0%

Gross Profit

$69.60K

-157.3%

Gross Margin

-13.93%

N/A

Market Cap

$61.80K

N/A

Market Cap/Employee

$1.54K

N/A

Employees

40

N/A

Net Income

$399.28K

+0.6%

EBITDA

$337.00K

-39.7%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Net Cash

$2.12M

-49.5%

Accounts Receivable

$92.68K

+21.9%

Inventory

$52.09K

-37.2%

Long Term Debt

$1.00M

+41.1%

Short Term Debt

$1.13M

+46.7%

Return on Assets

-16.29%

N/A

Return on Invested Capital

1.22%

N/A

Free Cash Flow

$10.26K

+45.4%

Operating Cash Flow

$10.26K

+45.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MJARFMJardin Group, Inc.
$0.00+0.00%
MODVQModivCare Inc.
$0.01+0.00%
EPGNFEpigenomics AG
$1.12+0.00%
IDTAIDenta Corp.
$0.25+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$175.81+0.02%
CDECoeur Mining
$17.88+0.01%
TSLATesla
$380.94+0.04%
SMCISuper Micro Computer
$21.62+0.05%

Questions About SZLSF

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.